COVID-19 antibodies persist at least nine months after infection

by Imperial College LondonA researcher testing a child as part of the study. Credit: Andrea CrisantiTesting of an entire Italian town shows antibody levels remain high nine months after SARS-CoV-

Updated on: April 10,2024

COVID-19 antibodies persist at least nine months after infection

by Imperial College LondonA researcher testing a child as part of the study. Credit: Andrea CrisantiTesting of an entire Italian town shows antibody levels remain high nine months after SARS-CoV-

Updated on:April 10,2024

Guidelines issued for vaccination in patients with rheumatic, musculoskeletal diseases

In new guidelines issued by the American College of Rheumatology, evidence-based recommendations are presented for the use of vaccinations in children and adults with rheumatic and musculoskeletal dis

Updated on: June 15,2024

Guidelines issued for vaccination in patients with rheumatic, musculoskeletal diseases

In new guidelines issued by the American College of Rheumatology, evidence-based recommendations are presented for the use of vaccinations in children and adults with rheumatic and musculoskeletal dis

Updated on:June 15,2024

New study points to a better way to ward off asthma triggers

by La Jolla Institute for ImmunologyLeft: Lung tissue of untreated mice. Right: Lung tissue of mice treated with antibodies blocking OX40L and CD30L. Credit: Dr. Gurupreet Sethi, La Jolla Institu

Updated on: May 05,2024

New study points to a better way to ward off asthma triggers

by La Jolla Institute for ImmunologyLeft: Lung tissue of untreated mice. Right: Lung tissue of mice treated with antibodies blocking OX40L and CD30L. Credit: Dr. Gurupreet Sethi, La Jolla Institu

Updated on:May 05,2024

'JEDI' technology awakens new understanding of how immune system works

by The Mount Sinai Hospital3D rendering of a T cell. Credit: CC BY 3.0, Blausen.com staff. "Blausen gallery 2014". Wikiversity Journal of Medicine. DOI:10.15347/wjm/2014.010. ISSN 20018

Updated on: April 16,2024

'JEDI' technology awakens new understanding of how immune system works

by The Mount Sinai Hospital3D rendering of a T cell. Credit: CC BY 3.0, Blausen.com staff. "Blausen gallery 2014". Wikiversity Journal of Medicine. DOI:10.15347/wjm/2014.010. ISSN 20018

Updated on:April 16,2024

T-cells shown to infiltrate brain, cause respiratory distress in condition affecting the immunocompromised

by Liz Ahlberg Touchstone |,University of Illinois at Urbana-ChampaignPulmonary dysfunction and mortality under the C-IRIS condition.ASchematic representation of the experiments and

Updated on: May 05,2024

T-cells shown to infiltrate brain, cause respiratory distress in condition affecting the immunocompromised

by Liz Ahlberg Touchstone |,University of Illinois at Urbana-ChampaignPulmonary dysfunction and mortality under the C-IRIS condition.ASchematic representation of the experiments and

Updated on:May 05,2024

Researchers discover potential new approach to treating psoriatic joint inflammation

by UC DavisCredit: CC0 Public DomainAn international team of researchers, led by UC Davis Health, has developed a new therapeutic approach to treating psoriatic arthritis, a chronic inflammatory

Updated on: June 17,2024

Researchers discover potential new approach to treating psoriatic joint inflammation

by UC DavisCredit: CC0 Public DomainAn international team of researchers, led by UC Davis Health, has developed a new therapeutic approach to treating psoriatic arthritis, a chronic inflammatory

Updated on:June 17,2024

mRNA-1273 induces stronger response than BNT162b2 for immunosuppressed

For immunosuppressed patients, mRNA-1273 induces a stronger seroresponse than BNT162b2, according to a research letter published online May 16 inJAMA Network Open.Jonathan Mitchell, M.B.B.S., fr

Updated on: April 20,2024

mRNA-1273 induces stronger response than BNT162b2 for immunosuppressed

For immunosuppressed patients, mRNA-1273 induces a stronger seroresponse than BNT162b2, according to a research letter published online May 16 inJAMA Network Open.Jonathan Mitchell, M.B.B.S., fr

Updated on:April 20,2024

Study in mice shows alterations in X-chromosome inactivation predispose female mammals to autoimmune disease

by Bob Yirka , Medical XpressPerturbation of X-inactivation in immune cells ofFtx−/−females.(A) Map of the X inactivation center showing the location ofXist(green) andFtx

Updated on: May 30,2024

Study in mice shows alterations in X-chromosome inactivation predispose female mammals to autoimmune disease

by Bob Yirka , Medical XpressPerturbation of X-inactivation in immune cells ofFtx−/−females.(A) Map of the X inactivation center showing the location ofXist(green) andFtx

Updated on:May 30,2024

How B cells fight the COVID-19 virus

by Sarah C.p. Williams,Broad Institute of MIT and HarvardResearchers discovered a new antibody (light blue) that neutralizes the COVID-19 virus, by binding to the virus’s spike protein (grey) an

Updated on: April 08,2024

How B cells fight the COVID-19 virus

by Sarah C.p. Williams,Broad Institute of MIT and HarvardResearchers discovered a new antibody (light blue) that neutralizes the COVID-19 virus, by binding to the virus’s spike protein (grey) an

Updated on:April 08,2024

Potentially predictive humoral immune response markers in COVID-19 patients

by Massachusetts General HospitalCredit: CC0 Public DomainGalit Alter, Ph.D., Group Leader at the Ragon Institute of MGH, MIT and Harvard and Professor of Medicine at Harvard Medical School, and

Updated on: April 10,2024

Potentially predictive humoral immune response markers in COVID-19 patients

by Massachusetts General HospitalCredit: CC0 Public DomainGalit Alter, Ph.D., Group Leader at the Ragon Institute of MGH, MIT and Harvard and Professor of Medicine at Harvard Medical School, and

Updated on:April 10,2024

Serum IL-35 levels tied to bone loss with rheumatoid arthritis

Serum interleukin (IL)-35 levels are associated with bone loss and may represent a novel therapeutic target for postmenopausal women with rheumatoid arthritis (RA), according to a study published onli

Updated on: June 06,2024

Serum IL-35 levels tied to bone loss with rheumatoid arthritis

Serum interleukin (IL)-35 levels are associated with bone loss and may represent a novel therapeutic target for postmenopausal women with rheumatoid arthritis (RA), according to a study published onli

Updated on:June 06,2024

Scientists discover two cellular defects appear to drive disease in lupus

byNorthwestern UniversityCredit: Pixabay/CC0 Public DomainNorthwestern Medicine and Brigham and Women's Hospital scientists have discovered a molecular defect that promotes the pathologic im

Updated on: July 11,2024

Scientists discover two cellular defects appear to drive disease in lupus

byNorthwestern UniversityCredit: Pixabay/CC0 Public DomainNorthwestern Medicine and Brigham and Women's Hospital scientists have discovered a molecular defect that promotes the pathologic im

Updated on:July 11,2024